Key result
CPB-assisted bioprosthetic AVR succeeds for mother and fetus in acute Staph aureus endocarditis at 22 weeks.
Why the study?
Can CPB-assisted aortic valve replacement be successfully performed in a pregnant patient with complicated acute endocarditis?
Case Report (n=1)
Can CPB-assisted aortic valve replacement be successfully performed in a pregnant patient with complicated acute endocarditis?
Demonstrates that CPB-assisted aortic valve replacement can be successfully performed during the second trimester of pregnancy despite severe complications of acute endocarditis.
Supports feasibility of CPB-assisted AVR in second-trimester pregnancy with acute endocarditis; hypothesis-generating and should not yet change practice.
A 27-year-old, G(3)P( 2)A(0) female with acute Staph aureus (SA) endocarditis successfully underwent CPB-assisted aortic valve replacement with a bioprosthetic aortic valve at 22 weeks' gestation. This patient's presentation of acute endocarditis complicated by septic shock, congestive heart failure, severe aortic insufficiency, multiple septic embolic events and borderline renal failure appeared on the daunting background of chronic heavy tobacco usage, hepatitis C positivity, long-term IV drug abuse and a pregnancy into its twenty-second week. Optimal treatment strategies implemented for both mother and fetus throughout the perioperative period contributed to a successful outcome for both.
No takes yet. Share an insight, caveat, or question.
Marcoux et al. (2009) conducted a case report in Acute Staph aureus endocarditis (n=1). CPB-assisted aortic valve replacement with a bioprosthetic aortic valve was evaluated on Successful outcome for mother and fetus. CPB-assisted aortic valve replacement with a bioprosthetic valve was successfully performed in a 27-year-old pregnant woman at 22 weeks' gestation with acute Staph aureus endocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: